問卷

TPIDB > Principal Investigator

Principal Investigator


Linkou Chang Gung Medical Foundation (在職)

Division of Hematology & Oncology

更新時間:2023-09-19

王博
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2019-09-15 - 2027-05-31

Phase I/II

A Phase I/IIa, Open-label, Multicenter Study of the Safety and Efficacy of CHO-H01 as a Single Agent to Subjects with Refractory or Relapsed Non-Hodgkin's Lymphoma
  • Condition/Disease

    Refractory or Relapsed Non-Hodgkin's Lymphoma

  • Test Drug

    CHO-H01

Participate Sites
7Sites

Not yet recruiting1Sites

Recruiting6Sites